Recommendations to assure the quality, safety and efficacy of Group A Meningococcal Conjugate vaccines

ECBS 2006

Recommendations for the production and control of group C meningococcal conjugate vaccines, TRS 926, Annex 3

Recommendations for the production and control of Meningococcal group C conjugate vaccines, TRS 924, 2004, Annex 2

Requirements for Meningococcal Polysaccharide vaccine (Amendment 1999) TRS 904, 2002 Annex 2

Requirements for meningococcal polysaccharide vaccine, Addendum 1980, TRS 658 Annex 6

Requirements for Meningococcal Polysaccharide vaccine: Adopted 1975, TRS 594, Annex 2


TRS 1004 - WHO Expert Committee on Biological Standardization, Sixty-seventh report


  • WHO Working Group meeting on Respiratory Syncytial Virus (RSV) Vaccine Standardization, WHO headquarters, Geneva, Switzerland, 13-15 September 2017
  • WHO Second Working Group Meeting on Developing WHO Guidelines on safe production of polio vaccines, WHO HQ Salle D, 19-20 September 2017
  • WHO Workshop on Implementation of Good Manufacturing Practices for Biological Products, Bangkok, Thailand 15-17 November 2017
  • WHO Implementation Workshop on the Quality, Safety and Efficacy of Typhoid Conjugate Vaccines, Osong, Chungju-si, The Republic of Korea, 21-13 November 2017


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971